Skip to main content
Top
Published in: Advances in Gerontology 4/2019

01-10-2019 | Arterial Occlusive Disease

Phytopharmacological Correction of Functional State, Hormonal Status, and Memory Performance in Patients of Different Ages with Organic Changes in Brain Vasculature

Authors: V. I. Vetosheva, V. V. Volodin, S. O. Volodina

Published in: Advances in Gerontology | Issue 4/2019

Login to get access

Abstract

A course of medication with the Kardisten dietary supplement normalizes an elevated blood cortisol level and optimizes the activity of brain vasculature to improve the functional state and enhance short- and long-term memory performance, especially in subjects younger than 50. Kardisten evokes a more pronounced decrease of cortisol level and improves memory performance more efficiently in the case of initial organic changes in the brain vasculature as compared to advanced atherosclerosis. Kardisten activates the natural mechanisms of enhanced functional capacity in the human organism, exerts a favorable effect on mature and elderly persons, and can be recommended for physical and mental health improvement and the preservation of an active lifestyle during aging.
Footnotes
1
Kardisten, bioactive dietary supplement (Certificate no. R.77.99.88.003.Е.000440.02.17 from February 1, 2017; OOO Biofarm-Komi, Russia; TU (Technical Specification) 10.89.19-001-24939466-16).
 
2
The state of brain vasculature was assessed by A.E. Popov, physician of superior expert category, Head of the Functional and Ultrasound Diagnostics Division of the Republican Hospital.
 
Literature
1.
go back to reference Andreeva, L.I., Boikova, A.A., Bykova, A.A., and Volodin, V.V., The effect of the new ecdysteroid-containing drug Serpisten on behavior and the cell adaptation in rats under heat stress, Teor. Prikl. Ekol., 2012, no. 1, pp. 36–43. Andreeva, L.I., Boikova, A.A., Bykova, A.A., and Volodin, V.V., The effect of the new ecdysteroid-containing drug Serpisten on behavior and the cell adaptation in rats under heat stress, Teor. Prikl. Ekol., 2012, no. 1, pp. 36–43.
2.
go back to reference Vein, A.M., Preface to the collection of scientific papers on the emotional processes, in Rol’ emotsional’nogo stressa v geneze nervno-psikhicheskikh zabolevanii (Role of Emotional Stress in Genesis of Neuropsychiatric Diseases), Moscow, 1977, pp. 3–4. Vein, A.M., Preface to the collection of scientific papers on the emotional processes, in Rol’ emotsional’nogo stressa v geneze nervno-psikhicheskikh zabolevanii (Role of Emotional Stress in Genesis of Neuropsychiatric Diseases), Moscow, 1977, pp. 3–4.
3.
go back to reference Volodin, V.V. and Mataev, S.I., Ecdysteroid-containing plants as sources of new adaptogens, Vestn. Biotekhnol. Fiz.-Khim. Biol., 2011, vol. 7, no. 2, pp. 52–59. Volodin, V.V. and Mataev, S.I., Ecdysteroid-containing plants as sources of new adaptogens, Vestn. Biotekhnol. Fiz.-Khim. Biol., 2011, vol. 7, no. 2, pp. 52–59.
4.
go back to reference Luriya, A.R., Vnimanie i pamyat’ (Attention and Memory), Moscow: Progress, 2001. Luriya, A.R., Vnimanie i pamyat’ (Attention and Memory), Moscow: Progress, 2001.
5.
go back to reference Man’kovskii, N.B. and Belonog, R.P., The action of Rantarin on the elderly people, in Biologicheskie resursy Vostochnoi i Yugo-Vostochnoi Azii i ikh ispol’zovanie (Biological Resources of Eastern and Southeastern Asia and Their Use), Vladivostok, 1978, pp. 101–110. Man’kovskii, N.B. and Belonog, R.P., The action of Rantarin on the elderly people, in Biologicheskie resursy Vostochnoi i Yugo-Vostochnoi Azii i ikh ispol’zovanie (Biological Resources of Eastern and Southeastern Asia and Their Use), Vladivostok, 1978, pp. 101–110.
6.
go back to reference Volodin, V.V. and Volodina, S.O., RF Patent 2153346, Byull. Izobret., 2000, no. 21. Volodin, V.V. and Volodina, S.O., RF Patent 2153346, Byull. Izobret., 2000, no. 21.
7.
go back to reference Selye, H., In vivo: The Case for Supramolecular Biology, New York: Liveright, 1967. Selye, H., In vivo: The Case for Supramolecular Biology, New York: Liveright, 1967.
8.
go back to reference Sudakov, K.V., Social and biological aspects of psychoemotional stress: protection against undesirable consequences, Vestn. Mezhdunar. Akad. Nauk, 2006, no. 1, pp. 8–14. Sudakov, K.V., Social and biological aspects of psychoemotional stress: protection against undesirable consequences, Vestn. Mezhdunar. Akad. Nauk, 2006, no. 1, pp. 8–14.
9.
go back to reference Tkachev, A.V., Boiko, E.R., Gubkina, Z.D., et al., Endokrinnaya sistema i obmen veshchestv u cheloveka na Severe (Human Endocrine System and Metabolism in the North), Syktyvkar, 1992. Tkachev, A.V., Boiko, E.R., Gubkina, Z.D., et al., Endokrinnaya sistema i obmen veshchestv u cheloveka na Severe (Human Endocrine System and Metabolism in the North), Syktyvkar, 1992.
10.
go back to reference Fitoekdisteroidy (Phytoecdysteroids), Volodin, V.V., Ed., St. Petersburg: Nauka, 2003. Fitoekdisteroidy (Phytoecdysteroids), Volodin, V.V., Ed., St. Petersburg: Nauka, 2003.
11.
go back to reference Khavinson, V.Kh., Morozov, V.G., and Malinin, V.V., Molecular physiology of aging, Usp. Gerontol., 2001, vol. 7, pp. 65–71. Khavinson, V.Kh., Morozov, V.G., and Malinin, V.V., Molecular physiology of aging, Usp. Gerontol., 2001, vol. 7, pp. 65–71.
12.
go back to reference Shchekina, E.G. and Drogovoz, S.M., The relationship of side effects and action mechanisms of psychotropic drugs, Provizor, 2008, no. 5, pp. 58–61. Shchekina, E.G. and Drogovoz, S.M., The relationship of side effects and action mechanisms of psychotropic drugs, Provizor, 2008, no. 5, pp. 58–61.
13.
go back to reference Yaremenko, K.V., Optimal’noe sostoyanie orgnaisma i adaptogeny (Optimal State of Organism and Adaptogens), St. Petersburg, 2008. Yaremenko, K.V., Optimal’noe sostoyanie orgnaisma i adaptogeny (Optimal State of Organism and Adaptogens), St. Petersburg, 2008.
14.
go back to reference Schwarz, R.M., Cognitive response to stress: experimental study of an information processing model of intrusive and repetitive thought, Diss. Abstr. Int., 1979, vol. 39, no. 11-B, pp. 5585–5586. Schwarz, R.M., Cognitive response to stress: experimental study of an information processing model of intrusive and repetitive thought, Diss. Abstr. Int., 1979, vol. 39, no. 11-B, pp. 5585–5586.
15.
go back to reference Willis, S.L., Introduction to special section on cognitive training in later adulthood, Dev. Psychol., 1990, vol. 26, pp. 875–878.CrossRef Willis, S.L., Introduction to special section on cognitive training in later adulthood, Dev. Psychol., 1990, vol. 26, pp. 875–878.CrossRef
16.
go back to reference Panossian, A. and Wikman, G., Effect of adaptogens on central nervous system, Arguivos Brasil. Fitomed. Cient., 2005, vol. 3, no. 1, pp. 29–51. Panossian, A. and Wikman, G., Effect of adaptogens on central nervous system, Arguivos Brasil. Fitomed. Cient., 2005, vol. 3, no. 1, pp. 29–51.
Metadata
Title
Phytopharmacological Correction of Functional State, Hormonal Status, and Memory Performance in Patients of Different Ages with Organic Changes in Brain Vasculature
Authors
V. I. Vetosheva
V. V. Volodin
S. O. Volodina
Publication date
01-10-2019
Publisher
Pleiades Publishing
Published in
Advances in Gerontology / Issue 4/2019
Print ISSN: 2079-0570
Electronic ISSN: 2079-0589
DOI
https://doi.org/10.1134/S2079057019040155

Other articles of this Issue 4/2019

Advances in Gerontology 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine